Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cumberland Pharmaceuticals (CPIX) Cash & Current Investments (2016 - 2026)

Cumberland Pharmaceuticals' Cash & Current Investments history spans 16 years, with the latest figure at $11.4 million for Q4 2025.

  • On a quarterly basis, Cash & Current Investments fell 36.29% to $11.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was $11.4 million, a 36.29% decrease, with the full-year FY2025 number at $11.4 million, down 36.29% from a year prior.
  • Cash & Current Investments hit $11.4 million in Q4 2025 for Cumberland Pharmaceuticals, down from $15.2 million in the prior quarter.
  • Over the last five years, Cash & Current Investments for CPIX hit a ceiling of $27.0 million in Q4 2021 and a floor of $11.4 million in Q4 2025.
  • Historically, Cash & Current Investments has averaged $18.9 million across 5 years, with a median of $18.2 million in 2022.
  • Biggest five-year swings in Cash & Current Investments: rose 13.2% in 2024 and later crashed 36.29% in 2025.
  • Tracing CPIX's Cash & Current Investments over 5 years: stood at $27.0 million in 2021, then decreased by 26.93% to $19.8 million in 2022, then decreased by 7.27% to $18.3 million in 2023, then fell by 1.95% to $18.0 million in 2024, then plummeted by 36.29% to $11.4 million in 2025.
  • Business Quant data shows Cash & Current Investments for CPIX at $11.4 million in Q4 2025, $15.2 million in Q3 2025, and $16.1 million in Q2 2025.